197 related articles for article (PubMed ID: 36509284)
1. The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.
Kennel KB; Burmeister J; Radhakrishnan P; Giese NA; Giese T; Salfenmoser M; Gebhardt JM; Strowitzki MJ; Taylor CT; Wielockx B; Schneider M; Harnoss JM
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36509284
[TBL] [Abstract][Full Text] [Related]
2. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function.
Tambuwala MM; Cummins EP; Lenihan CR; Kiss J; Stauch M; Scholz CC; Fraisl P; Lasitschka F; Mollenhauer M; Saunders SP; Maxwell PH; Carmeliet P; Fallon PG; Schneider M; Taylor CT
Gastroenterology; 2010 Dec; 139(6):2093-101. PubMed ID: 20600011
[TBL] [Abstract][Full Text] [Related]
3. Knockout of Factor-Inhibiting HIF (
Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
[TBL] [Abstract][Full Text] [Related]
4. Prolyl hydroxylase 2 is dispensable for homeostasis of intestinal epithelium in mice.
Xie Y; Yuan T; Qin Y; Weng Z; Fang J
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):540-546. PubMed ID: 29688249
[TBL] [Abstract][Full Text] [Related]
5. β-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1α-mediated angiogenesis.
Huang C; Tan H; Wang J; Huang L; Liu H; Shi Y; Zhong C; Weng S; Chen C; Zhao W; Lin Z; Li J; Zhi F; Zhang B
Cancer Lett; 2024 Jul; 593():216940. PubMed ID: 38729554
[TBL] [Abstract][Full Text] [Related]
6. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
[TBL] [Abstract][Full Text] [Related]
7. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
[TBL] [Abstract][Full Text] [Related]
8. P-Cadherin Regulates Intestinal Epithelial Cell Migration and Mucosal Repair, but Is Dispensable for Colitis Associated Colon Cancer.
Naydenov NG; Lechuga S; Zalavadia A; Mukherjee PK; Gordon IO; Skvasik D; Vidovic P; Huang E; Rieder F; Ivanov AI
Cells; 2022 Apr; 11(9):. PubMed ID: 35563773
[TBL] [Abstract][Full Text] [Related]
9. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis-associated cancer.
Yang S; He X; Zhao J; Wang D; Guo S; Gao T; Wang G; Jin C; Yan Z; Wang N; Wang Y; Zhao Y; Xing J; Huang Q
Cancer Commun (Lond); 2021 Aug; 41(8):695-714. PubMed ID: 34160895
[TBL] [Abstract][Full Text] [Related]
11. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
Short SP; Pilat JM; Barrett CW; Reddy VK; Haberman Y; Hendren JR; Marsh BJ; Keating CE; Motley AK; Hill KE; Zemper AE; Washington MK; Shi C; Chen X; Wilson KT; Hyams JS; Denson LA; Burk RF; Rosen MJ; Williams CS
Gastroenterology; 2021 Apr; 160(5):1694-1708.e3. PubMed ID: 33388316
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses.
Strowitzki MJ; Kimmer G; Wehrmann J; Ritter AS; Radhakrishnan P; Opitz VM; Tuffs C; Biller M; Kugler J; Keppler U; Harnoss JM; Klose J; Schmidt T; Blanco A; Taylor CT; Schneider M
JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33784253
[TBL] [Abstract][Full Text] [Related]
13. T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model.
El-Hindi K; Brachtendorf S; Hartel JC; Oertel S; Birod K; Merz N; Trautmann S; Thomas D; Weigert A; Schäufele TJ; Scholich K; Schiffmann S; Ulshöfer T; Utermöhlen O; Grösch S
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163788
[TBL] [Abstract][Full Text] [Related]
14. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity.
Wang K; Ding Y; Xu C; Hao M; Li H; Ding L
Oncoimmunology; 2021 May; 10(1):1923910. PubMed ID: 34026335
[TBL] [Abstract][Full Text] [Related]
15. Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing.
Ahmad R; Kumar B; Thapa I; Tamang RL; Yadav SK; Washington MK; Talmon GA; Yu AS; Bastola DK; Dhawan P; Singh AB
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37815870
[TBL] [Abstract][Full Text] [Related]
16. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
[TBL] [Abstract][Full Text] [Related]
17. CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis.
Polosukhina D; Singh K; Asim M; Barry DP; Allaman MM; Hardbower DM; Piazuelo MB; Washington MK; Gobert AP; Wilson KT; Coburn LA
Oncogene; 2021 Nov; 40(47):6540-6546. PubMed ID: 34625710
[TBL] [Abstract][Full Text] [Related]
18. Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.
Wang J; Ding K; Wang Y; Yan T; Xu Y; Deng Z; Lin W; Zhang L; Zhu W; Zhao R; Zhou Y; Liu Z
Oxid Med Cell Longev; 2022; 2022():4061713. PubMed ID: 35927991
[TBL] [Abstract][Full Text] [Related]
19. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).
Thaker AI; Shaker A; Rao MS; Ciorba MA
J Vis Exp; 2012 Sep; (67):. PubMed ID: 22990604
[TBL] [Abstract][Full Text] [Related]
20. Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model.
Huo X; Liu D; Gao L; Li L; Cao L
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
